389 results on '"Gomez, D.R."'
Search Results
2. Inpatient Simulation Resource Utilization for Inpatient Radiation Oncology Consults
3. Clinical Sequalae of Initial Insurance Denials in a Large Academic Radiation Oncology Center
4. Harnessing Electronic Patient-Reported Outcomes (ePRO) in Routine Care to Promote Clinical Trial Enrollment: A Randomized Study
5. The Impact of Co-Alterations on Outcomes after Local Therapy for Patients with KRAS-Mutant Lung Adenocarcinoma Brain Metastases
6. AI Serial Image Prediction of Progression-Free Survival (PFS) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients Treated with Chemoradiation (CRT) and Durvalumab Consolidation
7. Prospective, Cell-Free Circulating Tumor DNA (ctDNA) Profiling in Locally Advanced Lung Cancer Treated with Chemoradiation
8. A Novel FDG PET and Mean Lung Dose Model to Identify Stage III NSCLC Patients at High Risk of Developing Early Radiation Pneumonitis
9. Addition of Metastasis-Directed Therapy to Standard of Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase II Trial
10. Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Patients with Pleural Metastases from Thymic Malignancies
11. Peripheral T-Cell Priming and Micrometastatic Disease Control with Metastasis-Directed Therapy: Multidimensional Immunogenomic Profiling of Oligometastatic Prostate Cancer in the EXTEND Trial
12. Disparities in Stage at Presentation among Hispanic and Latinx Patients with Non-Small Cell Lung Cancer
13. When Should we Irradiate the Primary in Metastatic Lung Cancer?
14. Final Analysis of Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression Trial - A Randomized Study of Stereotactic Body Radiotherapy for Oligoprogressive Metastatic Lung and Breast Cancers
15. Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer (EXTEND): A Multicenter, Randomized Phase II Trial
16. Tumor Mutational Burden Predicts Progression-Free Survival and Local-Regional Control in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Durvalumab
17. Biomarkers Associated with Pulmonary Exacerbations in a Prospective, Placebo-Controlled, Randomized Trial of Nintedanib for the Treatment of Radiation Pneumonitis
18. Treatment of Thymic Oligometastastic or Oligoprogressive Lesions with Hypofractionated Radiation Therapy or Stereotactic Body Radiation Therapy
19. Novel Inpatient Radiation Oncology Consult Service Associated with Improved Prognosis-Appropriate Care
20. CNS Outcomes in ALK Fusion Positive NSCLC Patients with BM Who Received Alectinib with or without Local Therapy
21. Factors Associated with Outcomes in Patients with Metastatic NSCLC Receiving Osimertinib and Consolidative Radiation Therapy
22. Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results from the Lead-In Phase of the Randomized Basket Trial EXTEND
23. Retrospective Review of the Safety of Osimertinib with Thoracic Radiotherapy
24. Neuromuscular Toxicity and Dose-Volume Relationships Following SBRT for Bone Oligometastases: Post-Hoc Analysis of Two Ongoing Clinical Trials
25. Stereotactic Body Radiotherapy for Sarcoma Pulmonary Metastases
26. P1.05-02 Mutations in CREBBP are Associated with Local Failure after Lung Stereotactic Body Radiation Therapy
27. EP05.01-025 Planned Interim Analysis of a Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer
28. EP05.01-014 Circulating Tumor DNA to Identify Genomic Biomarkers of Radiation Sensitivity in Locally Advanced Non-Small Cell Lung Cancer
29. Reproductive potential of Spodoptera eridania (Stoll) (Lepidoptera: noctuidae) in the laboratory: effect of multiple couples and the size/Potencial reprodutivo de Spodoptera eridania (Stoll) (Lepidoptera: Noctuidae) em laboratorio: efeito de multiplos casais e do tamanho
30. PO-1250 Exploring published acute esophagitis models to support improved clinical management in thoracic RT
31. 192P Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
32. Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression ― Interim Analysis of the First Randomized Study of Stereotactic Body Radiotherapy in Patients With Oligoprogressive Metastatic Cancers of the Lung and Breast
33. Enhancing Enrollment of Patients to Radiation Oncology Clinical Trials Across a Multi-Institutional Community-Academic Partnership: An Interrupted Time Series Analysis
34. Radiation Oncology-Specific Surveillance After Palliative Radiation Treatment for Spine and Non-Spine Bone Metastases
35. Effects of Liver Metastases and Liver-Metastasis-Directed Radiotherapy on Response to Immunotherapy
36. Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers
37. External Validation of Pulmonary Toxicity Risk Model for Ultracentral Lung Tumors
38. Standard vs. Higher-Dose Consolidative Thoracic Radiation in Extensive-Stage Small Cell Lung Cancer
39. Pre-Treatment Immune-Related Markers Predict Disease Outcomes in Non-Small Cell Lung Cancer Patients Treated With Chemoradiation and Durvalumab
40. The Correlation Between Changes in Cardiac Biomarkers and Cardiac Events in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Stereotactic Body Radiation Therapy (SBRT) — Exploratory Analysis of a Phase II Study
41. Safety and Effectiveness of Definitive Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer Among Older Patients: Does Frailty Matter?
42. Safety and Satisfaction of Patients Opting for Fully Remote Consultation and On-Treatment Management Visits During COVID-19
43. Survival and Patterns of Failure in Oligometastatic Esophagogastric Cancer
44. The Role of Radiation Oncology in Ethics Consultations
45. Durvalumab with Concurrent Definitive Radiation Therapy (DART) for Locally-Advanced Non-Small Cell Lung Cancer - A Phase II Study
46. Risk Factors Associated with Pulmonary Toxicities from Multiple Courses of Stereotactic Body Radiation Therapy (SBRT) for Synchronous or Metachronous Primary Lung Tumors or Lung Metastases
47. Exploring Associations between Immune Parameters and Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer after Chemoradiation and Durvalumab
48. One-Year Disease Outcomes in Stage III Non-Small Cell Lung Cancers Treated with Trimodality Therapy vs Concurrent Chemoradiation and Durvalumab
49. Circulating Tumor DNA as a Biomarker in Oligometastatic Non-small Cell Lung Cancer
50. Single Institution Experience of Proton and Photon Based Post-Operative Radiation Therapy for Non-Small Cell Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.